Momenta Pharmaceuticals to Webcast at Two Upcoming Investor Conferences

CAMBRIDGE, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will webcast its presentation at two upcoming investor conferences.

25th Annual Credit Suisse Healthcare Conference
Monday, November 7, 2016 at 1:00 p.m. MST in Scottsdale, AZ

Stifel 2016 Healthcare Conference
Wednesday, November 16, 2016 at 11:45 a.m. EST in New York, NY

The audio webcast of each presentation will be available live on the “Investors” section of the company’s website located at www.momentapharma.com. A replay of each presentation will be posted on the Momenta website approximately one hour after the event.

About Momenta
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex drugs and is headquartered in Cambridge, MA. Momenta is applying its technology to the development of generic versions of complex drugs, biosimilar and potentially interchangeable biologics, and to the discovery and development of novel therapeutics for autoimmune indications.

To receive additional information about Momenta, please visit the website at www.momentapharma.com, which does not form a part of this press release.

Our logo, trademarks, and service marks are the property of Momenta Pharmaceuticals, Inc. All other trade names, trademarks, or service marks are property of their respective owners.

Contact: Sarah Carmody Momenta Pharmaceuticals 1-617-395-5189 IR@momentapharma.com

Source:Momenta Pharmaceuticals, Inc.